BioCentury
ARTICLE | Clinical News

FDA issues handful of new PDUFA dates

February 22, 2019 7:15 PM UTC

With the government shutdown resolved, FDA has accepted a handful of applications for review during the beginning Feb. 18, according to company announcements.

FDA granted Priority Review to two applications from Genentech Inc. for entrectinib and polatuzumab vedotin...